Simulect (Basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors

Laura L Mulloy, F. Wright, M. L. Hall, M. Moore

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Simulect (Basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors'. Together they form a unique fingerprint.